21 USC § 812(C)(d)(2) explains synthetic cannabinoids (“cannabimimetic agents”) require
"binding studies” and “functional assays” before CSA scheduling. The process for CSA 2 scheduling is explained in Title 21 USC Controlled Substances Act, Part B §811. No such prerequisite scheduling action, binding study or assay exist for Hemp derived cannabinoids (synthetic or otherwise). Absent these prerequisites, and actual CSA listing, no Hemp derived
cannabinoid may be classified as synthetic, or regulated by the DEA.
The analogue act can’t be applied to a hemp derivative dont forget